Speech-Language Pathologists in Smithville, MO Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Ashley Beam, MSCCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 19209 Switchgrass Ct, Smithville, MO 64089 Phone: 816-986-0361

Mrs. Lindsey Kristine Lovelady, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 303 193rd St, Smithville, MO 64089 Phone: 816-797-9690

Mrs. Anita Jewell Cockrum, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14468 S 169 Highway, Smithville, MO 64089 Phone: 816-873-0212

Mrs. Megan Dawn Foster, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4809 Ne 92 Hwy, Smithville, MO 64089 Phone: 816-591-7988

Mrs. Beverly Jean Leachman, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5415 W Gale Cir, Smithville, MO 64089 Phone: 816-803-8802

News Archive

Face mask mandates reduced COVID-19 case rates, hospitalizations and deaths in Kansas

Despite facing cultural and political pushback, the evidence remains clear: Face masks made a difference in Kansas.

Views on Medicare feud: Both sides working toward cuts; If vouchers aren't the answer, what is?

Americans who don't count themselves confused by the current debate over Medicare must be in the minority. Mitt Romney and Republican running mate Rep. Paul D. Ryan accused President Obama of hurting seniors by cutting $716 billion from the federal health program. The president retorts that the Republicans would "end Medicare as we know it." The truth is that both sides have plans that dramatically change the nearly half-century-old program.

Impairment of specific gene increases susceptibility to opioid addiction and binge eating, study shows

Impairment of a particular gene raises increases susceptibility to opioid addiction liability as well as vulnerability to binge eating according to a new study.

Sciele Pharma files NDA for glycopyrrolate oral solution

Sciele Pharma, Inc., a Shionogi company, today announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for glycopyrrolate oral solution to treat chronic, moderate-to-severe drooling in pediatric patients. This condition often results from cerebral palsy as well as from other neurological disorders.

Read more Medical News

› Verified 3 days ago